英文名稱
N4,3',5'-Tribenzoyl,2'-deoxy-2'-methylene Cytidine
(2R,3S,5R)-5-(4-苯甲酰氨基-2-氧代嘧啶-1(2H)-基)-2-((苯甲酰氧基)甲基)-4-亞甲基四氫呋喃-3-基苯甲酸酯
純度
No Data Available
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
N4,3',5'-Tribenzoyl,2'-deoxy-2'-methylene Cytidine is an impurity of Sofosbuvir (P839640); a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled Sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase.